New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial.

Harm WienbergenAndreas FachJeanette ErdmannAlexander KatalinicNora EisemannPeter KrawitzCarlo MajOleg BorisovMatthias MunzMarkus NoethenRoza Meyer-SaraeiRico OstereschJohannes SchmuckerAxel LinkeIngo EitelRainer HambrechtHarald Langer

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2020)

The randomized multicenter NET-IPP study will evaluate for the first time the effects of a long-term web-based prevention program after MI on clinical events and risk factor control. In a genetic sub study the impact of disclosure of genetic risk using PRS will be investigated.

Keyphrases

phase iii
clinical trial
risk factors
double blind
public health
genome wide
open label
phase ii
copy number
quality improvement